Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Putative TPO receptor modulator discovered by Receptron scientists enters phase I

April 4, 2001

Two series of antitumor agents prepared and tested at Lafon

April 4, 2001

Twinstrand takes a novel approach to cancer treatment, as reported at AACR meeting

April 4, 2001

Phase II studies commence for Titan's gallium formulation

April 4, 2001

Ligand updates Targretin developments in the E.U.

April 4, 2001

Telik moves TLK-286 to phase II

April 4, 2001

AstraZeneca does not exercise option for TAPET-CPG2

April 4, 2001

Improved paclitaxel derivatives in development at The Liposome Company

April 3, 2001

Potential of halofuginone in cancer therapy highlighted in AACR presentation

April 3, 2001

DepoCyte recommended for approval by CPMP

April 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...